Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis
Multiple sclerosis is a debilitating disease of the central nervous system. It affects people of all ages but is more prevalent among 20-40 year olds. Patients with MS can be presented with potentially any neurological symptom depending on the location of the lesion. A quarter of patients with MS su...
Main Authors: | Thomas Low Tat Kuan, Farahnaz Amini, Marjan Seghayat |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-07-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_9000_655ba114f049f9d1cc7105ad57c81e21.pdf |
Similar Items
-
Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review
by: Daniel Levin, et al.
Published: (2022-12-01) -
Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
by: Álvaro Henrique-Neto, et al.
Published: (2021-02-01) -
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature
by: Francesco Patti, et al.
Published: (2022-02-01) -
CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01) -
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
by: Awadh Kishor Pandit, et al.
Published: (2015-01-01)